TGF-β and restenosis revisited: a Smad link

Pasithorn A Suwanabol1, K Craig Kent, Bo Liu

  • 1Department of Surgery, Division of Vascular Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Insights

Restenosis after vascular interventions remains a challenge. New research clarifies the complex role of transforming growth factor-beta (TGF-β) signaling in arterial remodeling, paving the way for targeted therapies.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Vascular Biology

Background:

  • Restenosis is a major complication following vascular interventions, hindering long-term success.
  • Transforming growth factor-beta (TGF-β) is upregulated at arterial injury sites and implicated in restenosis, primarily through fibrosis.
  • Emerging evidence suggests a more complex, multidirectional role for TGF-β in intimal thickening and arterial remodeling.

Purpose of the Study:

  • To redefine the precise role of TGF-β and its Smad signaling pathway in restenosis.
  • To explore the complex mechanisms of TGF-β in intimal thickening and arterial remodeling.
  • To identify potential targets for novel pharmacological therapies for restenosis.

Main Methods:

  • Review of recent advancements in understanding TGF-β signaling pathways.
  • Analysis of emerging data on TGF-β's role in intimal thickening and arterial remodeling.
  • Integration of knowledge on TGF-β and Smad signaling in the context of restenosis.

Main Results:

  • The role of TGF-β in restenosis is more complex than previously thought, extending beyond fibrosis.
  • TGF-β signaling pathways are critical in both intimal thickening and arterial remodeling.
  • Understanding the nuances of TGF-β/Smad signaling is crucial for addressing restenosis.

Conclusions:

  • Clarifying the multifaceted role of TGF-β signaling in restenosis is essential.
  • Targeting TGF-β and Smad pathways offers potential for innovative restenosis treatments.
  • Further research into TGF-β signaling will advance vascular intervention outcomes.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...